FCA dismisses appeal, patent not listable against STELARA SN

As previously reported, the Federal Court (FC) dismissed Janssen’s application for judicial review of the decision of the Office of Submissions and Intellectual Property (OSIP) refusing...

Related Keywords

Canada , Canadian , , Office Of Submissions , Janssen Incv Canada Health , Federal Court , Intellectual Property , Canadian Patent , Patent Register , Janssen Inc , Patented Medicines Notice , Compliance Regulations ,